RiMINI – The Influence of Rifaximin on Minimal Hepatic Encephalopathy (MHE) and on the Intestinal Microbiome in Patients With Liver Cirrhosis: Study Protocol for a Randomized Controlled Trial
Trials - United Kingdom
doi 10.1186/s13063-016-1205-8
Full Text
Open PDFAbstract
Available in full text
Date
February 29, 2016
Authors
Publisher
Springer Science and Business Media LLC